Retinoids

Jan 13, 2020

Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO(TM) (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)

Dec 19, 2019

FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris

Oct 15, 2019

Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference

Jan 17, 2019

Novel Oral Antibiotic Treatment Seysara(TM) (sarecycline) Now Available

Oct 11, 2018

Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months

Oct 11, 2018

Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO(TM) (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology

Jun 07, 2018

Amerigen Launches Generic Bexarotene Capsules

May 07, 2018

Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne

Mar 05, 2018

Leading Acne Brand Launches First-Ever Retinoid Education Week

Feb 01, 2018

Amneal Introduces Isotretinoin Capsules, USP

Oct 23, 2017

Sun Dermatology Launches ABSORICA® (isotretinoin) Tracker App to Help Patients Track Progress

Jun 05, 2017

Clementia Pharmaceuticals to Host Symposium at the 8th International Conference on Children's Bone Health